Arm/shoulder problems and insomnia symptoms in breast cancer survivors: Cross-sectional, controlled and longitudinal observations

Sleep Medicine

Volumn 12, Issue 6, 2011, Pages 584-590

  Dahl, Alv A ^a   Nesvold, Inger Lise ^a,b   Reinertsen, Kristin Valborg ^a,c   Fosså, Sophie D ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Arm shoulder pain; Breast cancer; HUNT 2; Insomnia symptoms; Lymphedema; Restricted shoulder mobility

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT; HYPNOTIC AGENT;

ADULT; AGED; ARM DISEASE; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; INSOMNIA; JOINT LIMITATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SHOULDER DISEASE;

ADULT; AGED; ARM; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LYMPHEDEMA; MIDDLE AGED; PREVALENCE; SHOULDER; SHOULDER PAIN; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVORS;

EID: 79958000074     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.01.011     Document Type: Article

References (34)

1. Sagen Å., Kåresen R., Sandvik L., Risberg M.A. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol 2009, 48:1111-1118.
2. Peuckmann V., Ekholm O., Rasmussen N.K., Groenvold M., Christiansen P., Møller S., et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 2009, 13:478-485.
3. Hopwood P., Haviland J.S., Sumo G., Mills J., Bliss J.M., Yarnold J.R., et al. Comparison of patient-reported breast, arm, and shoulder symptoms and body image for early breast cancer: 5-year follow-up in the randomised standardisation of breast radiotherapy (START) trials. Lancet Oncol 2010, 11:231-240.
4. Ahmed R.L., Prizment A., Lazovich D., Schmitz K.H., Folsom A.R. Lymphedema and quality of life in breast cancer survivors: the Iowa women's health study. J Clin Oncol 2008, 26:5689-5696.
5. Madsen A.H., Haugaard K., Soerensen J., Bokmand S., Friis E., Holtveg H., et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study by from the Danish Breast Cancer Cooperative Group. Breast 2008, 17:138-147.
6. Nesvold I.L., Fosså S.D., Holm I., Naume B., Dahl A.A. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol 2010, 49:347-353.
7. Montazeri A. Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008, 27:1-31.
8. The American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: The American Psychiatric Association; 1994. p. 557.
9. Savard J., Simard S., Blanchet J., Ivers H., Morin C.M. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001, 24:583-590.
10. Fiorentino L., Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006, 10:419-429.
11. Bardwell W.A., Profant J., Casden D.R., Dimsdale J.E., Ancoli-Israel S., Natarajan L. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psycho-Oncol 2008, 17:9-18.
12. LeBlanc M., Mérette C., Savard J., Ivers H., Baillargeon L., Morin C.M. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009, 32:1027-1037.
13. Koopman C., Nouriani B., Erickson V., Anupindi R., Butler R.D., Bachmann M.H., et al. Sleep disturbances in women with metastatic cancer. Breast J 2002, 8:362-370.
14. Holmen J., Midthjell K., Krüger Ø., Langhammer A., Lingaas Holmen T., Bratberg G.H., et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiol 2003, 13:19-32.
15. Reinertsen K.V., Cvancarova K., Wist E., Bjøro T., Dahl A.A., Danielsen T., et al. Thyroid function in women after multimodal treatment for breast cancer stage ii/iii: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys 2009, 75:764-770.
16. Sivertsen B., Overland S., Neckelmann D., Glozier N., Krokstad S., Pallesen S., et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol 2006, 163:1018-1024.
17. Overland S., Glozier N., Siversen B., Stewart R., Neckelmann D., Krokstad S., et al. A comparison of insomnia and depression as predictors of disability pension: the HUNT study. Sleep 2008, 31:875-880.
18. Sivertsen B., Krokstad S., Mykletun A., Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 Study. Behav Sleep Med 2009, 7:210-222.
19. Neckelmann D., Mykletun A., Dahl A.A. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007, 30:873-880.
20. Sprangers M.A.G., Groenvold M., Arraras J.I., Franklin J., te Velde A., Muller M., et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996, 14:2756-2768.
21. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., et al. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153.
22. Ware J.E., Snow K.K., Kosinski M. SF-36® health survey: manual and interpretation guide 2000, Quality Metric Inc., Lincoln, RI.
23. Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the hospital anxiety and depression scale, an updated literature review. J Psychosom Res 2002, 52:69-77.
24. Ware J.E., Gandek B., Kosinski M., Aaronson N.K., Apolone G., Brazier J., et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170.
25. Thorsen L., Nystad W., Dahl O., Klepp O., Bremnes R.M., Wist E., et al. The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer 2003, 39:1216-1221.
26. Cohen J. Statistical power analysis for the behavioral sciences 1988, Earlbaum, Hillsdale, NJ. 2nd ed.
27. Lipsey M.W., Wilson D.B. Practical meta-analysis 2001, Sage, Thousand Oaks, CA.
28. Nakagawa S., Cuthill I.C. Effect size, confidence interval and statistical significance. A practical guide for biologists. Biol Rev 2007, 82:591-605.
29. Morin C.M., Bélanger L., LeBlanc M., Ivers H., Savard J., Espie C.A., et al. The natural history of insomnia. A population-based 3-year longitudinal study. Arch Intern Med 2009, 169:447-453.
30. Omvik S., Pallesen S., Bjorvatn B., Sivertsen B., Havik O.E., Nordhus I.H. Patient characteristics and predictors of sleep medication use. Int Clin Psychopharmacol 2010, 25:91-100.
31. Sivertsen B., Omvik S., Pallesen S., Bjorvatn B., Havik O.E., Kvale G., et al. Cognitive behavioural therapy vs zopicline for treatment of chronic primary insomnia in older adults. JAMA 2006, 295:2851-2858.
32. Kripke D.F. Chronic hypnotic use: deadly risk, doubtful benefit. Sleep Med Rev 2000, 4:5-20.
33. Mallon L., Broman J.E., Hetta J. Is usage of hypnotics associated with mortality?. Sleep Med 2009, 10:279-286.
34. O'Donnell J.F. Insomnias in cancer patients. Clin Cornerstone 2004, 6(Suppl. 1D):S6-S14.